Gateway Investment Advisers’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.83M | Buy |
109,024
+60,308
| +124% | +$1.01M | 0.02% | 259 |
|
|
2025
Q1 | $749K | Buy |
48,716
+7,749
| +19% | +$119K | 0.01% | 359 |
|
|
2024
Q4 | $903K | Sell |
40,967
-915
| -2% | -$20.2K | 0.01% | 332 |
|
|
2024
Q3 | $755K | Hold |
41,882
| – | – | 0.01% | 350 |
|
|
2024
Q2 | $681K | Hold |
41,882
| – | – | 0.01% | 363 |
|
|
2024
Q1 | $591K | Hold |
41,882
| – | – | 0.01% | 379 |
|
|
2023
Q4 | $437K | Buy |
41,882
+9,312
| +29% | +$97.2K | 0.01% | 399 |
|
|
2023
Q3 | $332K | Buy |
+32,570
| New | +$332K | ﹤0.01% | 417 |
|